Valuation: Qiagen NV

Market Cap 9.4B 8.43B 7.84B 7.13B 13.38B 894B 13.49B 94.17B 36.79B 464B 35.28B 34.51B 1,487B P/E 2026 *
23.8x
P/E 2027 * 20.6x
Enterprise Value 10.06B 9.02B 8.4B 7.63B 14.32B 957B 14.44B 101B 39.4B 497B 37.78B 36.96B 1,593B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 4.33x
Free-Float
99.37%
Yield 2026 *
0.3%
Yield 2027 * 0.4%
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2026
Director of Finance/CFO 58 01/01/2004
Chief Operating Officer - 01/04/2022
Director TitleAgeSince
Director/Board Member 77 01/06/2011
Director/Board Member 60 08/01/2021
Director/Board Member 72 23/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-4.05% - - 9.4B
-2.01%-7.86%+54.60%+70.97% 70.44B
+3.84%-10.61%+6.97%+57.43% 50.31B
+3.35%+1.60%+10.58%+40.01% 47.51B
+0.51%+0.78%+28.58%+31.43% 42.91B
+2.70%-3.18%+296.96%+547.01% 40.39B
+0.69%-3.11%+7.48%+96.59% 39.69B
+0.06%-1.43%+10.47%+43.27% 30.59B
-2.95%-14.09%+37.94%+1.30% 26.8B
-0.39%-7.39%-13.33%-14.40% 22.36B
Average +0.35%-5.58%+48.92%+97.07% 41.22B
Weighted average by Cap. +0.69%-5.44%+51.90%+102.70%

Financials

2026 *2027 *
Net sales 2.14B 1.91B 1.78B 1.62B 3.04B 203B 3.06B 21.4B 8.36B 105B 8.02B 7.84B 338B 2.24B 2.01B 1.87B 1.7B 3.19B 213B 3.22B 22.48B 8.78B 111B 8.42B 8.24B 355B
Net income 418M 375M 349M 317M 595M 39.78B 600M 4.19B 1.64B 20.65B 1.57B 1.54B 66.19B 483M 433M 403M 366M 688M 45.97B 693M 4.84B 1.89B 23.86B 1.81B 1.77B 76.48B
Net Debt 666M 597M 556M 505M 948M 63.38B 956M 6.68B 2.61B 32.9B 2.5B 2.45B 105B 309M 277M 257M 234M 439M 29.36B 443M 3.09B 1.21B 15.24B 1.16B 1.13B 48.85B
Logo Qiagen NV
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2025, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.1%), the United States (47.8%), Americas (4.2%) and other (13.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Qiagen NV